Breast cancer is the second leading cause of cancer death in women worldwide. Breast cancer mortality has significantly decreased in recent decades as a result of advances in the diagnosis and treatment of the disease. However, in many patients the problem remains resistance to treatment and recurrence of the disease, which may be atributed to a small subset of cancer cells – cancer stem cells (CSCs). In addition to existing antitumour therapies which target differentiated tumour cells, targeting CSC could lead to a longer period without disease or a full recovery for breast cancer patients. Lysosomal cysteine peptidases, cathepsins B and X that have important role in different processes of development and progression of cancer, could serve as promising molecular targets. Identification of their targets and effects on key signaling pathways in CSCs is therefore necessary.
We isloated CSCs from breast cancer cell lines MDA-MB-231, MCF-10A neoT and MCF7, based on their ability to form tumorspheres. Using western blot analysis, we showed that the expression of cathepsins B and X in breast CSCs, isolated by tumorsphere formation, is increased compared to differentiated cells prior to CSCs isolation. Next, we demonstratedthe effect on cell signaling in breast CSCs by inhibiting cathepsins B and X. For this purpose, we determined the expression of selected proteins, involved in key signaling pathways of breast CSCs; pGSK3β, cyclin D1, βcatenin, TGFβ and NF-κB. Inhibition of cathepsins B and X had a significant effect on Wnt and TGF-β signaling pathways, while the effect on the NFκB signal pathway has not been demonstrated. Additionally, we determined the effect of
inhibiton of signal kinases on cathepsins B and X in the signaling pathways of breast CSCs. Using western blot analysis and by determining enzyme activity using enzyme kinetics we demonstrated that cathepsins B and X play an important role in signaling pathways JAK/STAT, Wnt, MAPK and PI3K and are involved also in Trk signaling and integrin receptor signaling.
We showed that cathepsins B and X are involved in many signaling pathways of breast CSCs. With that, we contributed to better understanding of the effect of cathepsins B and X inhibition on key signaling pathways in CSCs, which is important for understanding their molecular mechanisms and possibility of use in antitumour therapies.
|